1 |
Albala, C., Yanez, M., Devoto, E., Sostin, C., Zeballos, L. and Santos, J.L.: Obesity as a protective factor for postmenopausal osteoporosis. Int. J.Obes. Relat. Metab. Cisord. 20:1027-1032, 1996
|
2 |
Andersori, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D. and Galibert, L.: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179, 1997
DOI
PUBMED
ScienceOn
|
3 |
Collins, S., Kuhn, C.M., Petro, A.E., Swick, A.G., Chrunyk, B.A. and Surwit, R.S.: Role of leptin in fat regulation. Nature 380:677. 1996
DOI
PUBMED
ScienceOn
|
4 |
Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., Ohannesian, J.P., Macrco, C.C., McKee, L.J., Bauer, T.L. and Caro, J.F.: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292-295, 1996
DOI
ScienceOn
|
5 |
Felson, D.T., Zhang, Y., Hannan, M.T. and Anderson, J.J.: Effects of weight and body mass index on bone mineral density in men and women: The Framinhgam study. J. Bone Miner. Res. 8:567-573, 1993
|
6 |
Lengauer, C., Kinzler, K.W. and Vogelstein, B.: Genetic instabilities in human cancers. Nature 396:643-649, 1998
DOI
ScienceOn
|
7 |
Liu, B.Y., Guo, J., Lanske, B., Divieti, P., Kronenberg, H.M. and Bringhurst, F.R.: Conditionally immortalized murine bone marrow stromal cells mediate parathyroid hormonedependent osteoclastogenesis in vitro. Endocrinology 139: 1952-1964, 1998
DOI
ScienceOn
|
8 |
Matkovic, V., Ilich, J.Z., Badenhop, N.E., Skugor, M., Clairmont, A., Klisovic, D. and Landoll, J.D.: Gain in body fat is inversely related to the nocturnal rise in serum leptin level in young females. J. Clin. Endocrinol. Metab. 82: 1368-1372, 1997
DOI
ScienceOn
|
9 |
Pasco, J.A., Henry, M.J., Kotowicz, M.A., Collier, G.R., Ball, M.J., Ugoni, A.M. and Nicholson, G.C.: Serum leptin levels are associated with bone mass in nonobese women. J. Clin. Endocrinol. Metab. 86:1884-1887, 2001
DOI
ScienceOn
|
10 |
Roodman, G.D.: Cell biology of the osteoclast. Exp. Hematol. 27: 1299-1241, 1999
DOI
PUBMED
ScienceOn
|
11 |
Suda, T., Takahashi, N. and Martin, T.J.: Modulation of osteoclast differentiation. Endocrine Rev. 13:66-80, 1992
DOI
PUBMED
|
12 |
Hoover, P.A., Webber, C.E., Beaumont, .L.F. and Blake, J.M.: Postmenopausal bone mineral density: relationship to calcium intake, calcium absorption, residual estrogen, body composition, and physical activity. Can. J. Physiol. Pharmacol. 74:911-917, 1996
DOI
ScienceOn
|
13 |
Takahashi, N., Udagawa, N. and Suda, T.: A new member of tumor necrosis factor ligand family, RANKL/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256:449-455, 1999
DOI
ScienceOn
|
14 |
Takekoshi, K., Ishii, K., Nanmoku, T., Shibuya, S., Kawakami, Y., Isobe, K. and Nakai T.: Leptin stimulates catecholamine synthesis in a PKC-dependent manner in cultured porcine adrenal medullary chromaffin cells. Endocrinology 142:4861-4871, 2001
DOI
ScienceOn
|
15 |
Moonga, B.S. and Dempster, D.W.: Effects of peptide fragments of protein kinase C on isolated rat osteoclasts. Exp. Physiol. 83:717-725, 1998
DOI
|
16 |
Yamauchi, M., Sugimoto, T., Yamaguchi, T., Nakaoka, D., Kanzawa, M., Yano, S., Ozuru, R., Sugishita, T. and Chihara, K.: Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin. Endocrinol. 55:341-347, 2001
DOI
ScienceOn
|
17 |
Burgess, T.L., Qian, Y., Kaufman, S., Ring, B.D., Van, G., Capparelli, C., Kelley, M., Hsu, H., Boyle, W.J., Dunstan, C.R., Hu, S. and Lacey, D.L.: The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell Biol. 145:527-538, 1999
DOI
ScienceOn
|
18 |
Fleet, J.C.: Leptin and bone: does the brain control bone biology? Nutrition Rev. 58:209-211, 2000
DOI
ScienceOn
|
19 |
Minkin, C.: Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 34:285-290, 1982
DOI
PUBMED
ScienceOn
|
20 |
Cornish, J., Callon, K.E., Bava, U., Lin, C., Naot, D., Hill, B.L., Grey, A.B., Broom, N., Myers, D.E., Nicholson, G.C. and Reid, I.R.: Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 175:405-415, 2002
DOI
ScienceOn
|
21 |
Solin, M.S., Ball, M.J., Robertson, I. De Silva, A., Pasco, J., Kotowicz, M.A., Nicholson, G.C. and Collier, G.R.: Relationship of serum leptin to total and truncal body fat. Clin. Sci. 93:581-584, 1997
DOI
|
22 |
Reid, I.R., Ames, R., Evans, M.C., Sharpe, S., Gamble, G., France, J.T., Lim, T.M. and Cundy, T.F.: Determinants of total body and regional bone' mineral density in normal postmenopausal women-a key role for fat mass. J. Clin. Endocrinol. Metob. 75:45-51, 1992
DOI
|
23 |
Chambers, T.: Regulation of osteoclast development and function. In Rifkin B., Gay, C. edited. Biology and Physiology of the osteoclast. CRC Press, Boca Raton, FL, USA pp 105-128, 1992
|
24 |
Frost, H.M.: Metabolism of bone. N. Engl. J. Med. 289:864-865, 1973
|
25 |
Gordeladze, J.O., Drevon, C.A., Syversen, U. and Reseland, J.E.: Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J. Cell. Biochem. 85:825-836, 2002
DOI
ScienceOn
|
26 |
Lord, G.M., Matarese, G., Howard, J.K., Baker, R.J., Bloom, S.R. and Lechler, R.I.: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897-901, 1998
DOI
ScienceOn
|
27 |
Bado, A., Levasseur, S., Attoub, S., Kermorgant, S., Laigneau, J.P. Bortoluzzi, M.N., Moizo, L., Lehy, T., Guerre-Millo, M., LeMarchand-Brustel, Y. and Lewin, M.J.: The stomach is a source of leptin. Nature 394:790-793, 1998
DOI
PUBMED
ScienceOn
|
28 |
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A.F., Beil, F.T., Shen, J., Vinson, C., Rueger, J.M. and Karsenty, G.: Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207, 2000
DOI
ScienceOn
|
29 |
Steppan, C.M. and Swick, A.G.: A role for leptin in brain development. Biophy. Biochem. Res. Commun. 256:600-602, 1999
DOI
ScienceOn
|
30 |
Udagawa, N., Takahashi, N., Yasuda, H., Mizuno, A., Itoh, K., Ueno, Y., Shinki, T., Gillespie, M.T., Martin, T.J., Higashio, K. and Suda, T.: Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478-3484, 2000
DOI
ScienceOn
|
31 |
Kodama, H., Yamasaki, A., Nose, M., Niida, S., Ohgame, Y, Abe, M., Kumegawa, M. and Suda, T.: Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J. Exp. Med.173:269-272, 1991
DOI
ScienceOn
|
32 |
Anselme, K., Noel, B., Limosino, D., Bianchi, F., Morin, C. and Hardouin, P.: Comparative study of the in vitro characteristics of osteoblasts from paralytic and nonparalytic children. Spinal Cord 38:622-629, 2000
DOI
ScienceOn
|
33 |
Eastel, R.: Pathogenesis of postmenopausal osteoporosis. In Favus, M.J. edited. Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th ed. Philadelpia, PA : Lippincott Wiliams and Wilkins, pp 260-262, 1999
|
34 |
Iwaniec, U.T., Baumann, G., Heinzmann, U. and Atkinson, M.J.: Loss of the differentiated phenotype precedes apoptosis of ROS 17/2.8 osteoblast-like cells. Calcif. Tissue Int. 63: 208-213, 1998
DOI
ScienceOn
|
35 |
Laharrague, P., Larrouy, D., Fontanilles, A.M., Truel, N., Campfield, A, Tenenbaum, R., Galitzky, J., Corberand, J.X., Penicaud, L. and Casteilla, L.: High expression of leptin by human bone marrow adipocytes in primary culture. FASEB J. 12:747-752, 1998
|
36 |
Ogueh, O., Sooranna, S., Nicolaides, K.H. and Johnson, M.R.: The relationship between leptin concentration and bone metabolism in the human fetus. J. Clin. Endocrinol. Metab. 85:1997-1999, 2000
DOI
ScienceOn
|
37 |
Ravn, P., Cizza, G., Bjarnason, N.H., Thompson, D., Daley, M., Wasnich, R.D., McClung, M., Hosking, D., Yates, A.J. and Christiansen, C.: Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women. J. Bone Miner. Res. 14: 1622-1627, 1999
DOI
ScienceOn
|
38 |
Suda, T., Takahashi, N., Udagawa, N., limi, E., Gillespie, M.T. and Martin, T.J.: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Rev. 20:345-57, 1999
DOI
ScienceOn
|
39 |
Huang, L. and Cai, L.: Leptin: a multifunctional hormone. Cell Research 10: 81-92, 2000
DOI
ScienceOn
|
40 |
Mundy, G.R. and Roodman, G.D.: Osteoclast ontogeny and function, In Bone and Mineral Research, vol. 5, edited by Peck, W.A., pp 209-279, Elsevier, Amsterdam, 1987
|
41 |
Sierra-Honigmann, M.R., Nath, A.K., Murakami, C., GarciaCardena, G., Papapetropoulos, A., Sessa, W.C., Madge, L.A., Schechner, J.S., Schwabb, M.B., Polverini, P.J. and Flores-Riveros, J.R.: Biological action of leptin as an angiogenic factor. Science 281: 1683-1686, 1998
DOI
PUBMED
ScienceOn
|
42 |
Kondo, H., Guo, J. and Bringhurst, F.R.: Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J. Bone Miner. Res. 17:1667-1679, 2002
DOI
ScienceOn
|
43 |
Stein, G.S., Lian, J.B., Stein, J.L., Van Wijnen, A.J. and Montecino, M.: Transcriptional control of osteoblast growth and differentiation. Physiol. Rev. 76: 593-629, 1996
|
44 |
Santos-Alvarez, J., Goberna, R. and Sancez-Margalet, V.: Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 194: 6-11, 1999
DOI
ScienceOn
|
45 |
Cohen, B., Novick, D. and Rubinstein, M.: Modulation of insulin activities by leptin. Science 274:1185-1188, 1996
DOI
PUBMED
ScienceOn
|
46 |
Considine, R.V. and Caro, J.F.: Pleiotropic cellular effects of leptin. Curr. Opin. Endocrinol. Diabetes 6:163-169, 1999
DOI
ScienceOn
|
47 |
Gainsford, T., Willson, T.A., Metcalf, D., Handman, E., McFarlane, C., Ng, A., Nicola, N.A., Alexander, W.S. and Hilton, D.J.: Leptin can induce proliferation, differentiaion, and functional activation of hemopoietic cells. Proc. Natl. Acad. Sci. 93:14564-14568, 1996
DOI
|
48 |
Liu, C., Grossmann, A., Bain, S., Srachan, M., Puemer, D., Bailey, C., Humes, J., Lenox, J., Yamamoto, G., Sprugel, K., Kuijper, J., Weigle, S., Dunam, D. and Moore, E.: Leptin stimulates cortical bone formation in obese (ob/ob) mice. Annual Meeting of the ASBMR (abstract) S211 :50, 1997
DOI
ScienceOn
|
49 |
Klein, S., Coppack, S.W., Mohamed-Ali, V. and Landt, M.: Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45:984-987, 1996
DOI
ScienceOn
|
50 |
Shimabukuro, M., Koyama, K., Chen, G., Wang, M.Y., Trieu, F., Lee, Y., Newgard, C.B. and Unger, R.H.: Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Aacd. Sci. 94:4637-4641, 1997
DOI
ScienceOn
|
51 |
Steppan, C.M., Crawford, D.T., Chidsey-Frink, K.L., Ke, H. and Swick, A.G.: Leptin is a potent stimulator of bone growth in ob/ob mice. Regul. Pept. 92:73-78, 2000
DOI
PUBMED
ScienceOn
|
52 |
Hsu, H., Lacey, D.L., Dunstan, C.R., Solovyev, I., Colombero, A., Timms, E., Tan, H.L., Elliott, G., Kelley, M.J., Sarosi, I., Wang, L., Xia, X.L., Elliott, R., Chiu, L., Black, T., Scully, S., Capparelli, C., Morony, S., Shimamoto, G., Bass, M.B. and Boyle, W.J.: Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96:3540-3545, 1999
DOI
|
53 |
Nijweide, P.J., Burger, E.H. and Feyen, J.H.M.: Cells of bone: Proliferation, differentiation, and hormonal regulation. Physiol. Rev. 66:855-886, 1986
|
54 |
Ribot, C., Tremollieres, F. and Pouilles, J.M.: The effect of obesity on postmenopausal bone loss and the risk of osteoporosis. Adv. Natr. Res. 9:257-271, 1994
|
55 |
Wong, B.R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachilov, S., Cayani, E., Bartlett, III, F.S., Frankel, W.N., Lee, S.Y. and Choi, Y.: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activated c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:25190-25194, 1997
DOI
ScienceOn
|
56 |
Begg, S.K., Radley, J.M., Pollard, J.W., Chisholm, O.T., Stanley, E.R. and Bertoncello, I.: Delayed hematopoietic development in osteopetrotic (op/op) mice. J. Exp. Med. 177:237-242, 1993
DOI
ScienceOn
|
57 |
Holloway, W.R., Collier, F.M., Aitken, C.J., Myers, D.E., Hodge, J.M., Malakellis, M., Gough, T.J., Collier, G.R. and Nicholson, G.C.: Leptin inhibits osteoclast generation. J. Bone Miner. Res. 17:200-209, 2002
DOI
ScienceOn
|
58 |
Thomas, T., Gori, F., Khosla, S., Jensen, M.D., Burguera, B. and Riggs, B.L.: Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140: 1630-1638, 1999
DOI
ScienceOn
|
59 |
Barash, I.A., Cheung, C.C., Weigle, D.S., Kabigting, E.B., Kuijper, J.L., Clifton, D.K. and Steiner, R.A.: Leptin is a metabolic signal to the reproductive system. Endocrinology 137:3144-3147, 1996
DOI
ScienceOn
|
60 |
Ranganathan, S., Ciaraldi, T.P., Henry, R.R., Mudaliar, S. and Kern, P.A.: Lack of effect of leptin on glucose transport, lipoprotein lipase, and insulin action in adipose and muscle cells. Endocrinology 139:2509-2513, 1998
DOI
ScienceOn
|
61 |
Maor, G., Rochwerger, M., Segev, Y. and Phillip, M.: Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J. Bone Miner. Res. 17:1034-1043, 2002
DOI
ScienceOn
|
62 |
Tartaglia, L.A.: The leptin receptor. J. Biol. Chem. 272.:6093-6096, 1997
DOI
|
63 |
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. and Suda, T.: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclasto-genesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95:3597-3602, 1998
DOI
|
64 |
Klein, K.O., Larmore, K.A., de Lancey, E., Brown, J.M., Considine, R.V. and Hassink, S.G: Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J. Clin. Endocrinol. Metab. 83:3469-3475, 1998
DOI
ScienceOn
|
65 |
Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C.R., Lacey, D.L., Mak, T.W., Boyle, W.J. and Penninger, J.M.: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323, 1999b
DOI
PUBMED
ScienceOn
|